[Capreomycin damage to the plexus cochlearis].
D000818:Animals; D000995:Antitubercular Agents / Q000009:adverse effects*; D002196:Capillaries / Q000473:pathology; D002207:Capreomycin / Q000009:adverse effects; D002467:Cell Nucleus; D003051:Cochlea / Q000187:drug effects* / Q000503:physiopathology; D003594:Cytoplasmic Granules; D004847:Epithelial Cells; D006168:Guinea Pigs; D007759:Labyrinth Diseases / Q000139:chemically induced; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects; D013307:Streptomycin / Q000378:metabolism
D000995:Antitubercular Agents; D002207:Capreomycin; D013307:Streptomycin
Capreomycinschäden am Plexus cochlearis.